|
|
13:00 - 13:30: Registration note (Genopolys hall)
13:30 - 13:40: Welcome note
13:40 - 14:20: Keynote talk by Dr. Miguel Godinho Ferreira (IRCAN, France)
Cell autonomous and non-cell autonomous roles of telomerase in zebrafish cancer
14:20 -14:30: Sartorius. Essen Biosciences.
Live cell analysis using Incucyte® S3
14:30 - 15:30: Short talks:
14:30 – 14:50: Zuzana Cihlarova (IMG, Czech Republic)
The role of BRAT1 protein in DNA damage response and its links to genome instability
14:50 -15:10: Sébastien Relier (IGF/CNRS/University of Montpellier, France)
Reversible RNA modification steers colon cancer cell fate
15:10 – 15:30: Jean-Charles Walter (L2C/CNRS/University of Montpellier, France)
Biophysical modeling of translation in cancer cells
15:30 - 17:00: Coffee break and poster session 1 (Poster 1 to 13)
17:00 - 17:40: Keynote talk by Dr. Nicolas Manel (Curie Institute, France)
Activation of innate sensors by viruses and self
17:40 - 18:40: Short talks:
17:40-18:00: Ghita Chabab (IRCM, France)
Identification and characterization of regulatory γδ T cells and their role in the anti-tumor immunity
18:00-18:40: Short talks:
18:00 -18:20: Guillaume Belthier (IGF/University of Montpellier, France)
CD44v6: a new marker for circulating tumor cells (CTCs) isolation directly into the blood
18:20 -18:40: Monica Gabola (IGMM/University of Montpellier, France)
Loss of cyclin A2 in murine colonic epithelial cells disrupts colon homeostasis by triggering DNA damage
and dysplasia and high cyclin A2 expression is a good-prognosis factor in patients with colorectal cancer
19 :00 - 20:30 : Visit of the M.O.C.O
Panacée : 3 expositions : Caroline Achaintre / Estrid Lutz / Ambera Wellmann
14 Rue de l'École de Pharmacie, 34000 Montpellier
20:30 - 24:00: Social event : Le café de la Panacée
14 Rue de l'École de Pharmacie, 34000 Montpellier
9:00 - 9:40: Keynote talk by Dr. Andreu Casali (IRB, Spain)
How malignant cells disseminate from a primary tumor? Insights form a Drosophila model
9:40 - 10:40: Short talks
09:40 – 10:00: Magali Boyer (CHRU, France)
Liquid biopsy in Merkel Cell Carcinoma: detection of circulating tumor cells and
identification of the polyomavirus status in single tumor cells
10:00 – 10:20: Julie Olabe (INSERM, University Clermont Auvergne, France)
Role of tumor microenvironement in adreno-cortical carcinoma progression
10:20 – 10:40: Guillaume Tosato (IRCM, France)
Spatial intra-tumoral heterogeneity in liver metastasis from primary colorectal
tumor – a way for evolution and treatment resistance
10:40 - 11:00: Coffee break
11:00 – 11:40: Keynote talk by Dr. Daniel S. Peeper (NKI, Netherlands)
Towards rational cancer & immune cell therapy combinations - a functional genomics approach
11:40 – 13:00: Short talks
11:40-12:00: Julie Devin (IGH/ University of Montpellier, France)
Ironomycin Induces Diffuse Large B-Cell Lymphoma Cell Death By Targeting
Iron Metabolism Addiction
12:00 -12:20: Hélène Guillorit (IGF, University of Montpellier, France)
Targeting cancer stem cells with antibiotics
12:20 -12:40: Domenico Sorrentino (CRCT/ University of Toulouse, France)
Therapeutic modulation of autophagy in ALK positive anaplastic large cell lymphoma
12:40 - 13:00: Philip Vlummens (University of Brussels, Belgium)
Inhibition of the protein arginine methyltransferase PRMT5 in high-risk multiple myeloma as a novel treatment approach
13:00-14:00: Lunch
14:00- 15:30: Coffee break and poster session 2 (Poster 14 to 25)
15:30 – 16:10: Keynote talk by Dr. Hervé Chneiweiss (CNRS, France)
Current challenging ethical issues in oncology research
16:10-16:40: Discussion
16:40 – 16:50: Short talk/ poster awards and closing remar